| Literature DB >> 26990989 |
Jung-Hyun Kim1, Melody C Baddoo2, Eun Young Park1, Joshua K Stone1, Hyeonsoo Park3, Thomas W Butler1, Gang Huang4, Xiaomei Yan4, Florencia Pauli-Behn5, Richard M Myers5, Ming Tan1, Erik K Flemington2, Ssang-Taek Lim3, Eun-Young Erin Ahn6.
Abstract
Dysregulation of MLL complex-mediated histone methylation plays a pivotal role in gene expression associated with diseases, but little is known about cellular factors modulating MLL complex activity. Here, we report that SON, previously known as an RNA splicing factor, controls MLL complex-mediated transcriptional initiation. SON binds to DNA near transcription start sites, interacts with menin, and inhibits MLL complex assembly, resulting in decreased H3K4me3 and transcriptional repression. Importantly, alternatively spliced short isoforms of SON are markedly upregulated in acute myeloid leukemia. The short isoforms compete with full-length SON for chromatin occupancy but lack the menin-binding ability, thereby antagonizing full-length SON function in transcriptional repression while not impairing full-length SON-mediated RNA splicing. Furthermore, overexpression of a short isoform of SON enhances replating potential of hematopoietic progenitors. Our findings define SON as a fine-tuner of the MLL-menin interaction and reveal short SON overexpression as a marker indicating aberrant transcriptional initiation in leukemia.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26990989 PMCID: PMC4799497 DOI: 10.1016/j.molcel.2016.02.024
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970